Product Images Rivfloza
View Photos of Packaging, Labels & Appearance
- image_47 - export 00
- image_46 - export 01
- image_45 - export 02
- image_44 - export 03
- image_43 - export 04
- image_42 - export 05
- image_41 - export 06
- image_40 - export 07
- image_39 - export 08
- image_38 - export 09
- image_37 - export 10
- image_36 - export 11
- image_34 - export 12
- image_33 - export 13
- image_32 - export 14
- image_31 - export 15
- image_30 - export 16
- image_29 - export 17
- image_28 - export 18
- image_27 - export 19
- image_26 - export 20
- image_25 - export 21
- image_24 - export 22
- image_23 - export 23
- image_22 - export 24
- image_21 - export 25
- image_20 - export 26
- image_19 - export 27
- image_18 - export 28
- image_17 - export 29
- image_16 - export 30
- image_15 - export 31
- image_14 - export 32
- image_13 - export 33
- image_12 - export 34
- image_11 - export 35
- image_10 - export 36
- image_09 - export 37
- image_08 - export 38
- image_07 - export 39
- image_06 - export 40
- image_04 - export 41
- image_03 - export 42
- figure_1 - figure 1
- image_05 - image 01
- image_35 - image 02
- sleeve_128mg - sleeve 128mg
- sleeve_160mg - sleeve 160mg
- sleeve_80mg - sleeve 80mg
- structural_formula - structural formula
Product Label Images
The following 50 images provide visual information about the product associated with Rivfloza NDC 0169-5307 by Novo Nordisk, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image_47 - export 00

This text provides dosage information for a medication, specified as 80mg per 5 mL, intended for individuals aged 1 to 11 years who weigh more than 110 pounds (50 kilograms). It is important to follow the recommended dosage guidelines based on age and weight for safe and effective use of the medication.*
image_31 - export 15

This text indicates a color range from colorless to yellow. It may be describing a scale of chromatic variations or color changes.*
image_29 - export 17

This text appears to be a date format, denoted as "EXP YYYY-MM-DD", where YYYY-MM-DD represents the year, month, and day in a specific date. This format is commonly used for date expiration or validity dates, such as in documents, licenses, or products.*
image_28 - export 18

This is a list of medical supplies: cotton balls, gauze, sharps disposal container. These items are commonly used in healthcare settings for wound care and safe disposal of sharp objects.*
image_26 - export 20

This is a list of medical supplies including cotton balls or gauze for wound care, and a sharps disposal container for safe disposal of sharp medical instruments.*
image_25 - export 21

This is a description of a set that includes RIVFLOZAvial(s) with rubber finger plunger, stopper grip rod, and one or two 1 mL syringes with attached 27-gauge needle.*
image_23 - export 23

This text provides dosage information based on age and weight for patients receiving medication in milligrams per milliliter (mg/mL). It specifies different dosages for patients aged 12 years and older weighing under 110 lbs (50 kg) and for patients aged 9 years to 60 years and older weighing 110 lbs (50 kg) or more.*
image_08 - export 38

A sharps disposal container is used for safe and proper disposal of used needles, syringes, and other sharp objects. It helps prevent injuries and infections by providing a secure way to dispose of medical waste.*
image_07 - export 39

This text mentions different components of a syringe: needle cap, barrel, finger plunger, removed grip rod. These are essential parts of a syringe used in medical injections.*
image_06 - export 40

This text appears to describe various parts of a needle and syringe set, including a barrel, plunger rod, cap, and grip. These components are essential for using a syringe to administer medication or perform medical procedures.*
figure_1 - figure 1

This is a table showing the "Percent Change from Baseline" at different study visits for the "RIVFLOZA" treatment group (N=23) compared to the placebo group (N=12). Study visits include Day 30, Day 60, Day 90, Day 120, Day 150, and Day 180. The data in the table indicate different values for percent change from baseline for each group at the specified time points.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.